Companies / Healthcare / UHS
Universal Health Services Inc (UHS)
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; capital resources; and various management services, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
Ticker UHS Exchange NYSE Sector Healthcare Industry Medical Care Facilities Market cap $11.07B 52-week range $140.08 - $246.33
Valuation Share price $186.02 (close of Nov 18, 2026) P/E (TTM) 7.96x Price to book 1.44x Price to free cash flow 9.92x Enterprise value $17.08B Book value per share $133.00
Price performance Period Change 1 day -3.10% 5 days -5.46% 1 month +0.50% 3 months +7.47% 6 months +9.90% Year to date -14.68% 1 year -18.71% 3 years +36.82% 5 years +47.84% 10 years +51.65% All time +14,597.87%
Short interest As of Oct 30, 2026 Short % of float 6.17% Shares short 2.55M Days to cover 3.58 Change since prior report -3.45% Source FINRA consolidated short interest
Members of Congress who disclosed UHS trades Alan Armstrong · Julia Letlow
Super investors holding UHS First Eagle Investment (First Eagle Investment Management, LLC) · Richard Pzena (Pzena Investment Management) · Ray Dalio (Bridgewater Associates) · Ken Griffin (Citadel) · Lee Ainslie (Maverick Capital LTD)
Profitability and growth Return on equity 20.29% Return on invested capital 12.26% Return on assets 9.59% Return on capital employed 16.23% Net margin 8.57% EBITDA margin 15.05% Revenue growth 9.71% Net income growth 30.36% Free cash flow growth -24.40%
Cash flow and balance sheet Free cash flow yield (TTM) 10.08% Current ratio 1.37x Net debt to EBITDA 2.16x
Latest reported year Period end Dec 31, 2025 Fiscal year 2025 Revenue $17.36B EBITDA $2.61B Net income $1.49B Earnings per share $23.42 Interest expense $156.07M Shares outstanding 63.58M
Income statement by year Period end Revenue Net income EPS 2025-12-31 $17.36B $1.49B $23.42 2024-12-31 $15.83B $1.14B $17.16 2023-12-31 $14.28B $717.79M $10.35 2022-12-31 $13.40B $675.61M $9.23 2021-12-31 $12.64B $991.59M $11.99 2020-12-31 $11.56B $943.95M $11.06 2019-12-31 $11.38B $814.85M $9.16 2018-12-31 $10.77B $779.71M $8.35 2017-12-31 $10.41B $752.30M $7.86 2016-12-31 $9.77B $702.41M $7.22
Margins and returns by year Period end Net margin Return on equity Return on capital 2025-12-31 8.57% 20.29% 12.26% 2024-12-31 7.22% 16.92% 11.51% 2023-12-31 5.03% 11.58% 8.25% 2022-12-31 5.04% 11.33% 7.07% 2021-12-31 7.84% 16.01% 9.76% 2020-12-31 8.17% 14.74% 9.94% 2019-12-31 7.16% 14.61% 9.86% 2018-12-31 7.24% 14.27% 9.92% 2017-12-31 7.23% 14.89% 10.08% 2016-12-31 7.19% 15.28% 9.99%
Cash and debt by year Period end Cash Debt 2025-12-31 $137.80M $4.00B 2024-12-31 $125.98M $4.46B 2023-12-31 $119.44M $4.79B 2022-12-31 $102.82M $4.73B 2021-12-31 $115.30M $4.14B 2020-12-31 $1.22B $3.52B 2019-12-31 $61.27M $3.90B 2018-12-31 $105.22M $3.94B 2017-12-31 $74.42M $3.49B 2016-12-31 $33.75M $4.03B
Free cash flow by year Period end Free cash flow Stock-based compensation 2025-12-31 $849.25M $95.69M 2024-12-31 $1.12B $99.35M 2023-12-31 $524.74M $87.72M 2022-12-31 $262.02M $85.38M 2021-12-31 $28.04M $73.69M 2020-12-31 $1.63B $65.84M 2019-12-31 $804.37M $69.43M 2018-12-31 $609.78M $66.58M 2017-12-31 $690.08M $56.74M 2016-12-31 $813.90M $48.11M
Dividend history Most recent payment Sep 1, 2026 Paid in the last twelve months $0.80 Payment date Dividend per share 2026-09-01 $0.20 2026-06-08 $0.20 2026-03-02 $0.20 2025-12-01 $0.20 2025-09-02 $0.20 2025-06-02 $0.20 2025-03-03 $0.20 2024-12-03 $0.20
Investor relations Past earnings dates Reported Fiscal period EPS estimate 2026-10-27 Sep 2026 $5.31 2026-07-27 Jun 2026 $5.66 2026-04-27 Mar 2026 $5.29 2026-02-25 Dec 2025 $5.92 2025-10-27 Sep 2025 $4.66 2025-07-28 Jun 2025 $4.85 2025-04-28 Mar 2025 $4.36 2025-02-26 Dec 2024 $4.19
Filings and sources Company website uhs.com SEC filings 10-K, 10-Q and 8-K on EDGAR Earnings calendar All upcoming reports
Similar companies DaVita Inc. (DVA) · HCA Healthcare, Inc. (HCA) · Abbott Laboratories (ABT) · Medtronic plc (MDT) · Stryker Corp (SYK) · HealthEquity, Inc. (HQY) · Boston Scientific Corp (BSX) · Veeva Systems Inc (VEEV)
All Healthcare companies
Understanding these figures
Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades